MOASC and ANCO letter to the California Department of Public Health

FEBRUARY IS:
National Cancer Prevention &
Gallbladder/Bile Duct Cancer Awareness MONTH

 

This Weekly’s Hot Topics

  • MOASC and ANCO letter to the California Department of Public Health MOASC News
  • Recruiting sites for a CML trial. MOASC News/Clinical Trials News
  • AB 1400 removed from being voted on. California News
  • Prescription Drug Affordability bill held in Committee, unable to pass. California News
  • Governor & lawmakers to bring back paid covid-19 sick leave. California News

MOASC and ANCO (Association of Northern California Oncologists) represent thousands of patients in California who are fighting cancer and the care teams that treat them. Together, the two associations have sent a joint letter to the California Department of Public Health (CDPH) to encourage them to amend AFL 21-08.7, to protect California’s cancer patients who are more vulnerable to complications from infection with SARS-CoV2. The current active CDPH policy allows health facilities in the state, at critical staff shortage, to have health care providers return to work with patients without isolation after testing positive for COVID if asymptomatic. To read more click here and go to MOASC News.

Yesterday, California lawmakers declined to vote on AB 1400, a high-profile effort to overhaul California’s healthcare system, putting an end to a proposal that would have guaranteed medical coverage to every resident by levying billions in new taxes. AB 1400 would have created a publicly financed healthcare system called CalCare, which could cost between $314 billion and $391 billion in state and federal funds, according to a legislative analysis. The Progressive Caucus of the California Democratic Party threatened to withhold endorsements from any Assembly member that did not vote for AB 1400. To read more click here and go to California News.

Noridian will make system updates to allow additional diagnosis codes with procedure codes 0242U, 0239U and 0037U. Noridian determined additional diagnosis codes are allowed per NCD 90.2, Next Generation Sequencing, based on the instruction in CMS Change Request 12124, “International Classification of Diseases, 10th Revision (ICD-10) and Other Coding Revisions to National Coverage Determination (NCDs)–July 2021.” This change is for dates of service on or after 07/01/21. To read more click here and go to Medicare News/Noridian News.

The Centers for Medicare & Medicaid Services released their annual update to the Medicare & Medicaid Spending by Drug datasets with data for 2020. The datasets focus on average spending per dosage unit for prescription drugs in the Medicaid, Medicare Part B, and Medicare Part D programs, and track the change in average spending per dosage unit over time. The 2020 data and all previous years of the Medicare & Medicaid Spending by Drug data are available. Below are two of them which may be of interest. To read more click here and go to Medicare News/CMS News.

To read the full edition of the California Oncology Weekly Newsletter, click on the date below.

February 1, 2022



No comments have been posted yet.